Both the NHAS and the NVHAP expire in 2020.

Scientists aren’t sure, but they know that the risk that a previous case of liver cancer will return remains high for those cured of hep C.

Baby boomers still make up the largest bloc of those with the virus, but youths’ injection drug use is sending their infection rates upward.

A hepatologist shares lessons learned and advice for others in the field.

Hepatitis C knocked pro wrestler Devon “Hannibal” Nicholson out of the ring, but a cure landed him back in the fight.

Devon Nicholson’s hep C diagnosis affected his pro wrestling career. But today, he is cured and back in the ring.

A group of experts has issued a call to arms, spotlighting missed opportunities for addiction treatment in hospital settings.

A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)

It remains crystal clear that people and communities who are at risk need to speak up as often as possible.

Chris Taylor bids farewell to 12 years of hepatitis advocacy with the National Alliance of State and Territorial AIDS Directors (NASTAD).